BlueCrest Capital Management »

Exagen shares owned by BlueCrest Capital Management

Quarter-by-quarter ownership of Exagen (XGN) shares owned by BlueCrest Capital Management from 13F filings

Historical chart of BlueCrest Capital Management investment in Exagen

Tip: Access up to 7 years of quarterly data

All positions including Exagen held by BlueCrest Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Exagen by BlueCrest Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $61k 10k 6.08

More positions owned by BlueCrest Capital Management

Ishares Tr Core S&p500 Etf (IVV)
Spdr Gold Tr Gold Shs Call Option (GLD)
Vistra Energy (VST)
PG&E Corporation (PCG)
Select Sector Spdr Tr State Street Fin (XLF)
Wells Fargo & Company (WFC)
Citigroup Com New (C)
Bank of America Corporation (BAC)
Kraneshares Trust Csi Chi Internet (KWEB)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Criteo S A Spons Ads (CRTO)
Vaneck Etf Trust Gold Miners Etf (GDX)
Ishares Msci Brazil Etf Call Option (EWZ)
Ishares Tr Msci India Etf (INDA)
Echostar Corp Note 3.875%11/3 (Principal)

View all positions for BlueCrest Capital Management

Top funds holding Exagen

Rtw Investments
Vanguard Group
Balyasny Asset Management
Silvercrest Asset Management Group
Kennedy Capital Management
Wexford Capital
Acadian Asset Management
Mink Brook Asset Management
Susquehanna International
FourWorld Capital Management
Nano Cap New Millennium Growth Fund
Millennium Management
Marshall Wace
Two Sigma Investments
Jane Street

View all funds holding Exagen